Skip to main content

CHTP News

5 Stocks Under $10 Set to Soar

These under-$10 stocks look poised to trade higher from current levels.

Lundbeck to Buy Chelsea Therapeutics for $658M

Central nervous system disorder specialist Chelsea Therapeutics International on Thursday said it had signed up to a bid from Denmark's H. Lundbeck that values its stock at up to $658 million.

Why Chelsea Therapeutics (CHTP) Stock Is Soaring Today

Chelsea Therapeutics (CHTP) soared Thursday amid news that Danish pharmaceutical company H. Lundbeck would takeover the company for up to $658 million.

Chelsea Exits in Victory With Lundbeck Takeout

Chelsea CEO Joe Oliveto and his team deserve a lot of credit for cleaning up some messy Northera clinical trials, scoring at the FDA advisory panel, securing the drug's approval and now delivering on the exit strategy that everyone wanted.

'Mad Money' Lightning Round: Zynga Can Go Higher

Cramer is staying away from Solazyme but thinks Retrophin is too frothy.

Breaking News

Disney Mobile Game Opens Up a New Universe

Familiar Disney characters populate an alternate reality in new interactive game.

Netflix Lays Offs More Employees To Cut Costs

Netflix layoffs continue as the streaming giant executes a plan to cope with slow revenue growth.

Something Strange is Happening With Home Prices

As mortgage rates hit fresh highs, there's something unusual going on with the real estate market.

Roe Decision Forces Disney, Netflix to Take a Political Stand

Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.